| ²é¿´: 1978 | »Ø¸´: 22 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
ÕâÑùµÄÉó¸åÒâ¼û£¬ÎÒµÄÎÄÕÂÔõô·¢ÄØ£¿
|
|||
|
È¥ÄêÉó¸åÒâ¼û»ØÀ´ÁË£¬µ±Ê±ÎÒ¾ÍÕð¾ªÁË£¬Ò²Óеã»ÒÐÄ¡£¡£¡£¡£¡£ ½ñÄ껹ÊǵÃÊÕʰ£¬Çë´ó¼Ò°ïÎÒ¿´¿´Õâ¸öÉó¸åÒâ¼û. ÎÒÏë¼ÌÐø·¢Õâ¸öµµ´ÎµÄÓеãÎÊÌ⣬·¢µÍÒ»µãµÄÐв»£¿ÏÖÔÚÒ²²»¿ÉÄܲ¹ÊµÑéÁË£¬Ö»ÄÜÔÚд·¨ÉÏÐÞ¸ÄÁË¡£ Dear Dr., Thank you very much for submitting your above-mentioned manuscript for review to ####. After careful consideration, we have decided that your manuscript does not meet one or several of our criteria and must be rejected for publication. Specifically, I agree with the reviewer that the results you present are too preliminary to warrant publication at this stage. Unfortunately, due to the concerns described above, we cannot accept a revised version of your manuscript. I am sorry that we cannot be more positive on this occasion, but hope that you appreciate the reasons for this decision. Yours sincerely, ......................................................................................... Reviewers' comments: Much is needed to be improved for this study before ready for manuscript review. First, as it is written as a methods development, at least one target gene needs to be illustrate. There are no details on methodology either. Throughout the manuscript, there is not description of this gene? There is one published paper on this, another one referred to as submitted to Plos1. What is this gene? It is up to the author to explain, not the reviewer to find out through references. Why only 2 out of 6 used were effective? There is no explanation at all. |
» ²ÂÄãϲ»¶
085601²ÄÁϹ¤³ÌÕÒµ÷¼Á
ÒѾÓÐ11È˻ظ´
×Ü·Ö293Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
334·Ö Ò»Ö¾Ô¸ÎäÀí ²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
327Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
329Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
275Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
291Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
309Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
297Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
Ò»Ö¾Ô¸ÄϺ½ 335·Ö | 0856 | GPA 4.07 | ÓпÆÑоÀú
ÒѾÓÐ6È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ĿǰһƪSCIÂÛÎÄÕýÔÚÉó¸åÖУ¬µ«ÏÖÔÚ·¢ÏÖÁËÎÄÕÂÖеÄһЩÎÊÌ⣬Ôõô°ì
ÒѾÓÐ41È˻ظ´
Éó¸åÒâ¼û·µ»Ø£¬ÓиöÉó¸åÈËÒªÇó²Î¿¼ËûµÄһƪÎÄÕÂ
ÒѾÓÐ10È˻ظ´
ÎÄÕµÄÉó¸åÒâ¼û£¬´ó¼Ò°ïæ¿´¿´£¡
ÒѾÓÐ6È˻ظ´
Éó¸åÖз¢ÏÖ×÷ÕßһƪÏàËÆ¶È¼«¸ßµÄÎÄÕÂÒѾÔÚÁíÒ»ÆÚ¿¯ÔÚÏߣ¬¸ÃÔõô°ì£¿
ÒѾÓÐ63È˻ظ´
·¢½ð±ÒÇóÖú ÀÏʦÈÃÎÒ°ÑÎÄÕÂÖ±½Ó·¢¸øÉó¸åÈË Óʼþ¸ÃÔõôд
ÒѾÓÐ8È˻ظ´
TalantaÎÄÕ±»¾Ü£¬µ«Çë¸÷λ°ïÎÒ¿´¿´ÕâÑùµÄÉó¸åÒâ¼ûÊÇʲôÒâ˼
ÒѾÓÐ15È˻ظ´
ºÜÓÐȤ£ºµ±Reviewer±ä³ÉÎÄÕµĺÏ×÷Õßʱ£¬ÈçºÎ»Ø¸´ËûµÄÉó¸åÒâ¼û£¿Çë¸ßÈËÖ¸µã£¬Ð»Ð»£¡
ÒѾÓÐ35È˻ظ´
±à¼·¢´íÉó¸åÒâ¼û£¬µ«ÎÄÕÂÎÞ½øÕ¹£¬ÈçºÎ´¦Àí
ÒѾÓÐ9È˻ظ´
ÎÒ¸ø¹úÍâÆÚ¿¯ÎÄÕµÄÉó¸å½á¹ûºÍÉó¸åÒâ¼û
ÒѾÓÐ178È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
ÉÂÎ÷Àí¹¤´óѧ×ÊÔ´Óë»·¾³¡¢²ÄÁÏ»¯¹¤²¿·Öµ÷¼ÁÃû¶î£¬Àí¹¤¼æÊÕ
+1/200
Î÷ÄϽ»Í¨´óѧҽѧԺÕÐÊÕÉúÎïҽѧ¹¤³ÌºÍ²ÄÁÏÓ뻯¹¤×¨ÒµË¶Ê¿Ñо¿Éú
+1/182
¸£½¨Ê¦·¶´óѧÕÐÊÕ2026Ä껯ѧ¡¢²ÄÁÏ˶ʿ3-4Ãû
+1/90
¾Å½Ñ§ÔºÖÆÒ©¹¤³Ìרҵ˶ʿÄâ½ÓÊÕµ÷¼Á
+1/46
¡¾È«¶î½±Ñ§½ð+Ó¢¹ú²©Ê¿Ñ§Î»¡¿¹ú¿Æ´óº¼¸ßÔºNathan¿ÎÌâ×éÕÐÊÕ2026¼¶ÁªÅ಩ʿÉú1Ãû£¡
+1/44
ÑĮ̀´óѧ¾«×¼²ÄÁϸߵÈÑо¿Ôº26Äê²ÄÁÏ·½ÏòÑо¿ÉúÕÐÉú
+1/37
ÖÐɽ´óѧ£¨ÉîÛÚ£©ÈáÐÔµç×ÓѧԺ2026¼¶²©Ê¿ÉúÕÐÆ¸
+1/15
˫һÁ÷´óÑ§ÏæÌ¶´óѧ¡°»¯¹¤¹ý³ÌÄ£ÄâÓëÇ¿»¯¡±¹ú¼ÒµØ·½ÁªºÏ¹¤³ÌÑо¿ÖÐÐÄÕÐÊÕ²©Ê¿Éú
+1/14
»¯¹¤±ÏÒµÈýÄêתµç×ÓÐÅÏ¢¿ÉÐÐÂ𣿣¿¸÷λͬÐÐǰ±²
+1/11
ÆëÆë¹þ¶û´óѧ»¯Ñ§Ó뻯ѧ¹¤³ÌѧԺÕÐÊÕר˶µ÷¼Á
+1/10
»¯Ñ§¡¢»¯¹¤¡¢»¯×±Æ·¡¢²ÄÁϱ³¾°¿¼Éúµ÷¼Á
+1/7
Ìì½òÀí¹¤´óѧ¹ú¼Ò½ÜÇàÍõÌúÍŶÓÕÐÆ¸Ñ§Êõ¹Ç¸É¡¢²©Ê¿ºó
+1/7
ÖйúµØÖÊ´óѧ£¨Î人£©Çå½àÄÜÔ´Óë×ÊÔ´Ñ»·ÍŶӳÏÕпÆÑÐÖúÀí/2026¼¶Ë¶Ê¿¡¢²©Ê¿Éú/²©Ê¿ºó
+1/5
Öйú¿ÆÑ§Ôº´óѧÄÉÃ׿ÆÑ§Óë¼¼ÊõѧԺ-ÂÞñõ¿ÎÌâ×é³ÏÕÐ˶ʿÑо¿Éú
+1/5
ÉϺ£½»Í¨´óѧ³ÂÙ»èÝ¿ÎÌâ×éÕÐÊÕ2026ÄêÉêÇë-¿¼ºË²©Ê¿Éú1Ãû£¨ÄÜÔ´²ÄÁÏ·½Ïò£©
+1/5
Î人·ÄÖ¯´óѧ¹ú¼Ò½ÜÇà¿ÎÌâ×é³ÏÕе÷¼Á˶ʿÑо¿Éú
+1/3
ÁëÄÏ´óѧ£¨Ïã¸Û£©³ÏÕÐResearch Talent HubÈ˲ţ¨´´Ð¼°¿Æ¼¼»ù½ðÑо¿È˲ſ⣩
+1/3
292Çóµ÷¼Á
+1/3
¹ã¶«¹¤Òµ´óѧ»·¾³¿ÆÑ§Ó빤³ÌѧԺÕÐÊÕ˶ʿµ÷¼Á
+1/3
Ò׶ȲãÁ÷ÖÊÁ¿Á÷Á¿¼ÆÔÚº½¿Õ·¢¶¯»úѹËõ¿ÕÆø²âÊÔÖеÄÓ¦ÓÃ
+1/1
23Â¥2011-08-05 11:41:27
2Â¥2011-03-09 16:09:59
visitor958
ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 2283 (½²Ê¦)
- ¹ó±ö: 0.05
- ½ð±Ò: 17310
- Ìû×Ó: 15735
- ÔÚÏß: 2926.6Сʱ
- ³æºÅ: 489254
3Â¥2011-03-09 16:14:09
4Â¥2011-03-09 16:35:48














»Ø¸´´ËÂ¥